col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

78 Results       Page 1

American Physiological Society: AJP Lung Cellular and Molecular Physiology
  original article Date Title Authors   All Authors
1 [GO] 2024―Feb―27 Repetitive Sulfur Dioxide Exposure in Mice Models Post-Deployment Respiratory Syndrome Sergey S. Gutor, Rodrigo I. Salinas, David S. Nichols, Julia M. R. Bazzano, Wei Han, Jason J. Gokey, et al. (+8)
2 [GO] 2024―Jan―30 Aryl hydrocarbon receptor activation alters immune cell populations in the lung and bone marrow during coronavirus infection Alicia M. Healey, Kristina N. Fenner, Colleen T. O'Dell, B. Paige Lawrence
3 [GO] 2023―Dec―26 Does Vaping Increase the Likelihood of SARS-CoV-2 Infection? Paradoxically Yes and No Rattapol Phandthong, Man Wong, Ann Song, Teresa Martinez, Prue Talbot
4 [GO] 2023―Nov―07 The alveolar fibroproliferative response in moderate to severe COVID-19-related acute respiratory distress syndrome and one-year follow up Shiqi Zhang, Leonoor S. Boers, Justin de Brabander, Laura B. van den Heuvel, Siebe G. Blok, Robert F.J. Kullberg, et al. (+10)
5 [GO] 2023―Oct―24 Exercise ventilatory response after COVID-19: comparison between ambulatory and hospitalized patients Ivan Guerreiro, Aurélien Bringard, Mayssam Nehme, Idris Guessous, Lamyae Benzakour, Alix Juillet De Saint-Lager-Lucas, et al. (+2)
6 [GO] 2023―Oct―03 Chronic alcohol use primes bronchial cells for altered inflammatory response and barrier dysfunction during SARS-CoV-2 infection Kristen F. Easley, R. Clayton Edenfield, Megan Jane Lott, Ryan C. Reed, Jayasri Das Sarma, Ashish J. Mehta, et al. (+10)
7 [GO] 2023―Mar―28 SARS-CoV-2 E protein induces Toll like receptor 2-mediated neonatal lung injury in a model of COVID-19 viremia that is rescued by the glucocorticoid ciclesonide Heather L. Menden, Sherry M. Mabry, Aparna Venkatraman, Sheng Xia, Donald B. DeFranco, Wei Yu, Venkatesh Sampath
8 [GO] 2023―Feb―21 Mucociliary Clearance Augmenting Drugs Block SARS-Cov-2 Replication in Human Bronchial Epithelial Cells Javier Campos-Gomez, Courtney Fernandez Petty, Marina Mazur, Liping Tang, George M. Solomon, Reny Joseph, et al. (+7)
9 [GO] 2023―Jan―31 The SARS-CoV-2 Spike S1 Protein Induces Global Proteomic Changes in ATII-Like Rat L2 Cells that are attenuated by Hyaluronan James A. Mobley, Adam Molyvdas, Kyoko Kojima, Israr Ahmad, Tamas Jilling, Jian-Liang Li, et al. (+2)
10 [GO] 2022―Nov―08 Call for Papers: "In it for the long haul: understanding the lasting impact of COVID-19 on lung health and disease" Nathan W. Bartlett, Julie A. Bastarache, Wolfgang M. Kuebler, Eric P. Schmidt
11 [GO] 2022―Oct―11 Pneumonia in the third year of the pandemic: One eye on the pathogens, the other on the host Christina Julius, Mathias W Pletz, Jan Rupp, Martin Witzenrath, Grit Barten-Neiner, Gernot Rohde
12 [GO] 2022―Oct―04 Competitive Cleavage of SARS-CoV-2 Spike Protein and ENaC by Plasmin as a Potential Mechanism for COVID-19 Infection Yapeng Hou, Tong Yu, Tingyu Wang, Yan Ding, Yong Cui, Hongguang Nie
13 [GO] 2022―Aug―16 World Lung Day: Impact of "The big 5 lung diseases" in the context of COVID-19 Mark Cohen, Stephanie M. Levine, Heather J. Zar
14 [GO] 2022―Jun―28 Exploring antiviral and anti-inflammatory effects of thiol drugs in COVID-19 Kritika Khanna, Wilfred Raymond, Jing Jin, Annabelle R. Charbit, Irina Gitlin, Monica Tang, et al. (+15)
15 [GO] 2022―Jun―14 Absolute quantification of plasma mitochondrial DNA by droplet digital PCR marks COVID-19 severity over time during intensive care unit admissions Mark L. Hepokoski, Mazen Faris Odish, Michael T. Lam, Nicole G. Coufal, Mark L. Rolfsen, Gerald S. Shadel, et al. (+15)
16 [GO] 2022―May―24 Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness Eric D. Morrell, Pavan K. Bhatraju, Neha A. Sathe, Jonathan Lawson, Linzee Mabrey, Sarah E. Holton, et al. (+24)
17 [GO] 2022―Mar―23 Angiotensin-converting enzyme 2 in peripheral lung club cells modulates the susceptibility to SARS-CoV-2 in chronic obstructive pulmonary disease Yang Peng, Zhao-Ni Wang, Shi-Ying Chen, Ai-Ru Xu, Zhang-Fu Fang, Jing Sun, et al. (+8)
18 [GO] 2022―Feb―02 Woodsmoke particle exposure prior to SARS-CoV-2 infection alters antiviral response gene expression in human nasal epithelial cells in a sex-dependent manner Stephanie A Brocke, Grant T Billings, Sharon Taft-Benz, Neil E. Alexis, Mark T Heise, Ilona Jaspers
19 [GO] 2022―Jan―12 Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infection Ruobing Wang, Adam J. Hume, Mary Lou Beermann, Chantelle Simone-Roach, Jonathan Lindstrom-Vautrin, Jake Le Suer, et al. (+13)
20 [GO] 2022―Jan―11 Is there a shift of the oxygen-hemoglobin dissociation curve in COVID-19? Thomas Gille, Lucile Sesé, Eric Aubourg, Jean-François Bernaudin, Jean-Paul Richalet, Carole Planès
21 [GO] 2021―Nov―17 Ending AIDS and Stopping Pandemics Through Closing Inequalities Matthew M Kavanagh, Helena Nygren Krug
22 [GO] 2021―Oct―13 Control and challenge of COVID-19: lesson from China experience Na Zhu, Wenjie Tan
23 [GO] 2021―Sep―29 COVID-19 and COPD: Lesson beyond the pandemic David MG Halpin, Claus F Vogelmeier, Alvar Agusti
24 [GO] 2021―Sep―09 Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia Mada Ghanem, Méline Homps-Legrand, Marc Garnier, Lise Morer, Tiphaine Goletto, Justine Frija-Masson, et al. (+15)
25 [GO] 2021―Sep―07 The increased hemoglobin oxygen affinity in COVID-19 Dominik J. Vogel, Federico Formenti, Luigi Camporota
26 [GO] 2021―Aug―18 A Pediatric Perspective on World Sepsis Day in 2021 - Leveraging Lessons from The Pandemic to Reduce the Global Pediatric Sepsis Burden? Luregn J Schlapbach, Konrad Reinhart, Niranjan Kissoon
27 [GO] 2021―Aug―11 Lung Health in Africa: challenges and opportunities in the context of COVID-19 Obianuju B Ozoh, Bertrand Hugo Mbatchou Ngahane, Heather J Zar, Refiloe Masekela, Jeremiah Chakaya, Joseph Aluoch
28 [GO] 2021―Jul―07 Erythrocytes Identify Complement Activation in Patients with COVID-19 LK Metthew Lam, John Patrick Reilly, Ann H Rux, Sophia Murphy, Leticia Kuri-Cervantes, Ariel Weisman, et al. (+9)
29 [GO] 2021―Jun―22 The SARS-CoV-2 Spike Protein Subunit 1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells Ruben Colunga Biancatelli, Pavel Solopov, Elizabeth R Sharlow, John S Lazo, Paul Ellis Marik, John D Catravas
30 [GO] 2021―Jun―22 The significance of a lack of rhinorrhea in severe coronavirus 19 lung disease Michael Eisenhut
31 [GO] 2021―May―19 A Pilot Study to Assess the Circulating Renin-Angiotensin-System in COVID-19 Acute Respiratory Failure D. Clark Files, Kevin W. Gibbs, Christopher L. Schaich, Sean P. Collins, TanYa M. Gwathmey, Jonathan Dale Casey, et al. (+2)
32 [GO] 2021―May―12 The Oxygen Dissociation Curve of Blood in COVID-19 Dieter Böning, Wolfgang M. Kuebler, Wilhelm Bloch
33 [GO] 2021―May―05 The effect of estrogen in coronavirus disease 2019 (COVID-19) Qing Ma, Zhuo-wen Hao, Yan-feng Wang
34 [GO] 2021―Apr―06 In Silico investigation of the viroporin E as a vaccine target against SARS-CoV-2 Erasmia Rouka, Konstantinos I. Gourgoulianis, Sotirios G. Zarogiannis
35 [GO] 2021―Mar―24 Implications of pre-existing asthma on COVID-19 pathogenesis Rakhee K. Ramakrishnan, Saba Al Heialy, Qutayba Hamid
36 [GO] 2021―Mar―09 Molecular mechanisms of Na,K-ATPase dysregulation driving alveolar epithelial barrier failure in severe COVID-19 Vitalii Kryvenko, István Vadász
37 [GO] 2021―Feb―09 Carrageenan containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures Desiree Schütz, Carina Conzelmann, Giorgio Fois, Rüdiger Groß, Tatjana Weil, Lukas Wettstein, et al. (+6)
38 [GO] 2021―Jan―12 SARS-CoV-2 may hijack GPCR signaling pathways to dysregulate lung ion and fluid transport Reem Abdel Hameid, Estelle Cormet-Boyaka, Wolfgang M. Kuebler, Mohammed Uddin, Bakhrom K Berdiev
39 [GO] 2021―Jan―06 Remote ischemic conditioning for acute respiratory distress syndrome in COVID-19 Anthony V. Incognito, Philip J. Millar, W. Glen Pyle
40 [GO] 2021―Jan―06 Kinins and Chymase: The Forgotten Components of the Renin angiotensin system and their implications in COVID-19 Disease Zaid Abassi, Karl Skorecki, Dalit Ben Hamo-Giladi, Etty Kruzel-Davila, Samuel N Heyman
41 [GO] 2020―Dec―23 Healing after Covid-19: Are Survivors at Risk for Development of Pulmonary Fibrosis? Lindsay T McDonald
42 [GO] 2020―Dec―02 Deregulated miRNA expression is associated with endothelial dysfunction in post-mortem lung biopsies of COVID-19 patients. Ariana Centa, Aline S. Fonseca, Solange G. da Silva Ferreira, Marina Luise V. Azevedo, Caroline B. Vaz de Paula, Seigo Nagashima, et al. (+5)
43 [GO] 2020―Nov―25 Immunoglobulin Deficiency as an Indicator of Disease Severity in Patients with COVID-19 Faeq Husain-Syed, István Vadász, Jochen Wilhelm, Hans-Dieter Walmrath, Werner Seeger, Horst-Walter Birk, et al. (+19)
44 [GO] 2020―Nov―25 Angiotensin-Converting Enzyme 2 and COVID-19: Patients, Comorbidities, and Therapies Girish Pathangey, Priyal Praful Fadadu, Alexandra Raye Hospodar, Amr Abbas
45 [GO] 2020―Nov―11 Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections Mathew Suji Eapen, Wenying Lu, Tillie-Louise Hackett, Gurpreet K Singhera, Isobel E. Thompson, Kielan Darcy McAlinden, et al. (+6)
46 [GO] 2020―Nov―04 High-dimensional single-cell analysis reveals the immune characteristics of COVID-19 Wen Shi, Xiuxing Liu, Qiqi Cao, Pengjuan Ma, Wenqing Le, Lihui Xie, et al. (+6)
47 [GO] 2020―Oct―28 Angiotensin-converting enzyme 2 (ACE2) expression in COPD and IPF fibroblasts- the forgotten cell in COVID-19 Noof Aloufi, Hussein Traboulsi, Jun Ding, Gregory J Fonseca, Parameswaran Nair, Steven K. Huang, et al. (+3)
48 [GO] 2020―Oct―14 Hyperoxia and modulation of pulmonary vascular and immune responses in COVID-19 Dusan Hanidziar, Simon C Robson
49 [GO] 2020―Sep―30 Pneumonia in the face of COVID-19 Martin Witzenrath, Wolfgang Michael Kuebler
50 [GO] 2020―Sep―30 VITAMIN D SUPPLEMENTATION AS A RATIONAL PHARMACOLOGICAL APPROACH IN THE COVID-19 PANDEMIC Leon Ferder, Virna Margarita Martín Giménez, Felipe Inserra, Carlos Tajer, Laura Antonietti, Javier Mariani, Walter Manucha
51 [GO] 2020―Sep―30 Sex steroids skew ACE2 expression in human airway: A contributing factor to sex differences in COVID-19? Rama Satyanarayana Raju Kalidhindi, Niyati A Borkar, Nilesh Sudhakar Ambhore, Christina M Pabelick, YS Prakash, Venkatachalem Sathish
52 [GO] 2020―Sep―30 "World Pneumonia Day During a Global Pneumonia Pandemic: 12 November 2020" Leith Greenslade
53 [GO] 2020―Sep―09 Human coronaviruses 229E and OC43 replicate and induce distinct anti-viral responses in differentiated primary human bronchial epithelial cells Su-Ling Loo, Peter A. B. Wark, Camille Esneau, Kristy S Nichol, Alan C-Y Hsu, Nathan W Bartlett
54 [GO] 2020―Sep―03 Elevated FiO2 increases SARS-CoV-2 co-receptor expression in respiratory tract epithelium Despoina Myti, Miša Gunjak, Francisco Casado, Solmaz Khaghani Raziabad, Claudio Nardiello, István Vadász, et al. (+4)
55 [GO] 2020―Aug―12 Role of the renin angiotensin system in the development of severe COVID-19 in hypertensive patients Rodrigo Pacheco Silva-Aguiar, Diogo de Barros Peruchetti, Patricia Rieken Macedo Rocco, Alvin H Schmaier, Patricia Machado Rodrigues Silva, Marco Aurélio Martins, et al. (+3)
56 [GO] 2020―Aug―05 The potential role of the Carotid Body in COVID-19 Andrea Porzionato, Aron Emmi, Elena Stocco, Silvia Barbon, Rafael Boscolo-Berto, Veronica Macchi, Raffaele De Caro
57 [GO] 2020―Aug―05 SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs Rafal Bartoszewski, Michal Dabrowski, Bogdan Jakiela, Sadis Matalon, Kevin S. Harrod, Marek Sanak, James F. Collawn
58 [GO] 2020―Jul―22 Is there an association between the level of ambient air pollution and COVID-19 Baoming Wang, Hui Chen, Yik Lung Chan, Brian G. Oliver
59 [GO] 2020―Jul―15 SARS-CoV-2 (COVID-19) and Cystic Fibrosis Bruce A Stanton, Thomas H Hampton, Alix Ashare
60 [GO] 2020―Jul―08 DISEQUILIBRIUM BETWEEN THE CLASSIC RENIN-ANGIOTENSIN SYSTEM AND ITS OPPOSING ARM IN SARS-COV-2 RELATED LUNG INJURY Riccardo Sarzani, Federico Giulietti, Chiara Di Pentima, Piero Giordano, Francesco Spannella
61 [GO] 2020―Jun―17 NOVEL INSIGHTS ON THE PULMONARY VASCULAR CONSEQUENCES OF COVID-19 Francois Potus, Vicky Mai, Marius Lebret, Simon Malenfant, Emilie Breton-Gagnon, Annie C Lajoie, et al. (+3)
62 [GO] 2020―Jun―17 Assessment of ACE inhibitors/angiotensin receptor blockers in COVID-19 patients Krishna Sriram, Paul A. Insel
63 [GO] 2020―Jun―17 Potential role for nitazoxanide in treating SARS-CoV-2 infection Paulo Ricardo Martins-Filho, José Antônio Barreto-Alves, Ricardo Fakhouri
64 [GO] 2020―Jun―10 Consideration of Pannexin 1 channels in COVID-19 pathology and treatment Leigh Anne Swayne, Scott R Johnstone, Chen Seng Ng, Juan C Sanchez-Arias, Miranda E Good, Silvia Penuela, et al. (+5)
65 [GO] 2020―Jun―10 Is targeting Akt a viable option to treat advanced-stage COVID-19 patients? Payaningal R Somanath
66 [GO] 2020―Jun―10 Heparin as a Therapy for COVID-19: Current Evidence and Future Possibilities. Joseph Alan Hippensteel, Wells B LaRiviere, James F Colbert, Christophe J Langouët-Astrié, Eric P. Schmidt
67 [GO] 2020―Jun―04 Thoughts on the alveolar phase of COVID-19 Robert J. Mason
68 [GO] 2020―Jun―03 Understanding the age divide in COVID-19: Why are children overwhelmingly spared? Krithika Lingappan, Harry Karmouty-Quintana, Jonathan Davies, Bindu Akkanti, Matthew T Harting
69 [GO] 2020―May―28 P-selectin blockade in COVID-19-related ARDS Tommaso Neri, Dario Nieri, Alessandro Celi
70 [GO] 2020―May―20 Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells Kimberly E Stelzig, Fabrizio Canepa-Escaro, Marta Schiliro, Sergejs Berdnikovs, Y S Prakash, Sergio E Chiarella
71 [GO] 2020―May―13 Treatment of COVID-19 exacerbated asthma: should systemic corticosteroids be used? Kartik Kumar, Timothy SC Hinks, Aran Singanayagam
72 [GO] 2020―May―13 Urgent reconsideration of lung edema as a preventable outcome in COVID-19: Inhibition of TRPV4 represents a promising and feasible approach Wolfgang Michael Kuebler, Sven-Eric Jordt, Wolfgang B. Liedtke
73 [GO] 2020―May―04 Don’t judge too RAShly: the multifaceted role of the renin-angiotensin system and its therapeutic potential in COVID-19 Thomas Walther, Wolfgang M. Kuebler
74 [GO] 2020―May―04 Rigor before speculation in COVID-19 therapy Paul A. Welling, Daniel Batlle, James Brian Byrd, Louise M. Burrell, Andrew M. South, Matthew A. Sparks
75 [GO] 2020―May―04 Reply to Letter to the Editor: “Don’t judge too RAShly: the multifaceted role of the renin-angiotensin system and its therapeutic potential in COVID-19 Zaid A. Abassi, Karl Skorecki, Samuel N. Heyman, Safa Kinaneh, Zaher Armaly
76 [GO] 2020―Apr―08 Call for Papers: The pathophysiology of COVID-19 and SARS-CoV-2 infection Rory E. Morty, John Ziebuhr
77 [GO] 2020―Apr―01 COVID-19 - is the ACE2 just a foe? Hrvoje Jakovac
78 [GO] 2020―Mar―24 Covid-19 infection and mortality - A physiologist's perspective enlightening clinical features and plausible interventional strategies Zaid A. Abassi, Karl Skorecki, Samuel Noam Heyman, Safa Kinaneh, Zaher Armaly

78 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec